Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
Status:
Terminated
Trial end date:
2011-06-06
Target enrollment:
Participant gender:
Summary
To evaluate and compare the expression and change in expression of key severe asthma targets
at baseline in mile to moderate asthmatics vs. severe asthmatic subjects.
To evaluate and compare the airway pathology at baseline and changes in airway pathology in
relation to asthma severity.